Victory Pharma Inc., a specialty pharmaceutical company headquartered in San Diego, has agreed to pay $11,420,743 to resolve federal civil and criminal liability arising from its marketing of the pharmaceutical products Naprelan, Xodol, Fexmid, and Dolgic, the Justice Department announced today.
http://www.biospace.com/news_story.aspx?StoryID=283241&full=1
http://www.biospace.com/news_story.aspx?StoryID=283241&full=1
No comments:
Post a Comment